A Phase II-B, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety Of Efinopegdutide( MK6024-013) in Adults With Precirrhotic Nonalcoholic Steatohepatitis